The EGFR genotyping test revealed exon 19 deletion mutations in 74 (47.1%), L858R mutations in 74 (47.1%), uncommon mutations in 6 (3.8%), and complex mutations in 3 (2.0%) patients with NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.